Published in Intractable Rare Dis Res on November 01, 2016
Expression of GPR17, a regulator of oligodendrocyte differentiation and maturation, in Nasu-Hakola disease brains. Intractable Rare Dis Res (2017) 0.75
The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev (2007) 21.13
NADPH oxidase mediates lipopolysaccharide-induced neurotoxicity and proinflammatory gene expression in activated microglia. J Biol Chem (2003) 2.92
The genetic causes of basal ganglia calcification, dementia, and bone cysts: DAP12 and TREM2. Neurology (2005) 2.77
NADPH oxidase expression in active multiple sclerosis lesions in relation to oxidative tissue damage and mitochondrial injury. Brain (2012) 1.82
Nox family NADPH oxidases: Molecular mechanisms of activation. Free Radic Biol Med (2014) 1.68
Microglial dysfunction in brain aging and Alzheimer's disease. Biochem Pharmacol (2014) 1.52
Nasu-Hakola disease (polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy--PLOSL): a dementia associated with bone cystic lesions. From clinical to genetic and molecular aspects. Cell Mol Neurobiol (2004) 1.44
Gp91phox (NOX2) in classically activated microglia exacerbates traumatic brain injury. J Neuroinflammation (2010) 1.40
ROS-dependent signal transduction. Curr Opin Cell Biol (2014) 1.37
The microglial NADPH oxidase complex as a source of oxidative stress in Alzheimer's disease. J Neuroinflammation (2006) 1.25
Nasu-Hakola disease with a splicing mutation of TREM2 in a Japanese family. Eur J Neurol (2010) 1.17
Induction of gp91-phox, a component of the phagocyte NADPH oxidase, in microglial cells during central nervous system inflammation. J Cereb Blood Flow Metab (2001) 1.16
Targeting microglia-mediated neurotoxicity: the potential of NOX2 inhibitors. Cell Mol Life Sci (2012) 1.14
Clusters of activated microglia in normal-appearing white matter show signs of innate immune activation. J Neuroinflammation (2012) 1.09
Immunohistochemical characterization of microglia in Nasu-Hakola disease brains. Neuropathology (2010) 0.98
Neuropathology does not Correlate with Regional Differences in the Extent of Expansion of CTG Repeats in the Brain with Myotonic Dystrophy Type 1. Acta Histochem Cytochem (2010) 0.94
Microglial Hv1 proton channel promotes cuprizone-induced demyelination through oxidative damage. J Neurochem (2015) 0.82
LC3, an autophagosome marker, is expressed on oligodendrocytes in Nasu-Hakola disease brains. Orphanet J Rare Dis (2014) 0.81
Oligodendrocytes: Functioning in a Delicate Balance Between High Metabolic Requirements and Oxidative Damage. Adv Exp Med Biol (2016) 0.78
MicroRNA-Seq Data Analysis Pipeline to Identify Blood Biomarkers for Alzheimer's Disease from Public Data. Biomark Insights (2015) 0.87
TMEM119 marks a subset of microglia in the human brain. Neuropathology (2015) 0.79
Targeted sequencing approach to identify genetic mutations in Nasu-Hakola disease. Intractable Rare Dis Res (2016) 0.75
Expression of GPR17, a regulator of oligodendrocyte differentiation and maturation, in Nasu-Hakola disease brains. Intractable Rare Dis Res (2017) 0.75
Immunohistochemical characterization of CD33 expression on microglia in Nasu-Hakola disease brains. Neuropathology (2015) 0.75